Jared J Fradette

9PUBLICATIONS
40CO-AUTHORS
Molecular targetsRehabilitation engineeringCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 22, 2024
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors.

Bertha L Rodriguez, Jiawei Huang, Laura Gibson

|May 31, 2023
ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis.

Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian

|May 14, 2022
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis.

Rakhee Bajaj, Amanda N Warner, Jared F Fradette

|May 11, 2021
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.

David H Peng, B Leticia Rodriguez, Lixia Diao

|Dec 05, 2020
Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.

Jose A Monteiro de Oliveira Novaes, Taghreed Hirz, Irene Guijarro

Pageof 2